Apr. 23 at 3:58 PM
Strong open for
$BACHY — bulls in control early on.
But check this company — expanding from colorectal to pancreatic cancer with ColoAlert® showing 97% sensitivity. Strong trials, key partnerships, and FDA plans point to major U.S. growth in early cancer detection.
https://ritzherald.com/colorectal-to-pancreatic-mainz-biomed-expands-reach-in-early-cancer-detection/